Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Summary

The purpose of this study is to evaluate the effectiveness and tolerability of an investigational drug for the treatment of manic episodes of bipolar disorder. The investigational drug will be given as additional therapy to one of the five following medications: risperidone, olanzapine, quetiapine, ziprasidone, or aripiprazole. These medications are already FDA (Food and Drug Administration)-approved treatments for mania.

Timeline

Start

2004-11

Primary completion

2007-04

Completion

2007-04

Drugs

Indications